ISSN: 2149-2247 | E-ISSN: 2149-2549

Quick Search




Erciyes Medical Journal Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis [Erciyes Med J]
Erciyes Med J. 2020; 42(1): 108-109 | DOI: 10.14744/etd.2019.39114

Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis

Hatice Aslan Sırakaya, Mevlüde İnanç
Department of Internal Medicine, Kayseri Training and Research Hospital, Kayseri, Turkey

Neutropenic enterocolitis is an acute complication of neutropenia induced by chemotherapy, characterized by inflammatory processes involving the colon and cecum that can lead to necrosis, hemorrhage, perforation, and septicemia. Usually, this condition develops after use of cytotoxic drugs, and fever and abdominal pain are the main symptoms. We present a case of a 38 year old female patient with breast cancer who received doxorubicin and docetaxel and presented typhlitis.

Keywords: Neutropenic enterocolitis, neoadjuvant therapy, doxorubicin and docetaksel.

Hatice Aslan Sırakaya, Mevlüde İnanç. Neoadjuvant Doxorubicin and Docetaxel in Breast Cancer Patients Applied Neutropenic Enterocolitis. Erciyes Med J. 2020; 42(1): 108-109

Corresponding Author: Hatice Aslan Sırakaya, Türkiye
LookUs & Online Makale